New Search

If you are not happy with the results below please do another search

1122 search results for:

241

NK:IO raises more funding to advance pioneering NK cell therapy

NK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2 million (about US$1.5 million). This brings total equity financing to £3.2 million and will enable the company to reach key milestones in progressing its differentiated NK cell therapy candidates into […]

242

Celonic Group appoints new CEO

Celonic Group, a Swiss-based Biologics Contract Development and Manufacturing Organization (CDMO), has appointed Dr Samanta Cimitan as the Chief Executive Officer (CEO) of the Celonic Group, a subsidiary of the independent and privately owned J. Rettenmaier & Söhne Company (JRS Group).

243

Evotec signs 3-year agreement for unlimited use of Titian Software’s Mosaic Sample Management Platform

Titian Software, a global leader in life sciences sample management software, and the life science company Evotec have signed a three-year agreement to expand their collaboration around Titian Software’s Mosaic Sample Management Platform. Mosaic forms part of Evotec’s plans to expand and harmonise sample management throughout the organisation, underpinning its expanding services. The new agreement […]

244

Arrayjet partners with Chemspace to amplify its small molecule microarray services

Arrayjet, a leading provider of inkjet liquid-handling solutions, has partnered with Chem-space, the largest online catalogue of small molecules and biologics, to augment and streamline the company’s small molecule microarray (SMM) service offering. Chemspace’s curated and deeply annotated compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for assay development, contract screening and contract […]

245

ENPICOM secures more financing to extend data-driven antibody discovery

ENPICOM, an innovative bioinformatics software engineering company, has secured further financial backing from its current investors BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital. This underscores investor confidence in ENPICOM’s vision, unique technological capabilities, and exceptional track record in serving customers in the pharmaceutical and biotech industries.

247

TransCure bioServices expands reach into APAC with Preclina partnership

TransCure bioServices, a humanized mouse model CRO, has partnered with Preclina, a South Korean preclinical CRO specializing in autoimmune and inflammatory diseases. The partnership significantly expands TransCure’s reach into the APAC region, while also bolstering its service offerings to further enhance the quality of its research results.

248

Coriolis Pharma and Rhea­Vita collab to advance drug development with novel freeze-drying technology

Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of bio-pharmaceutical drugs, will collaborate with RheaVita in an effort to pave the way for drug development of biologics using RheaVita’s novel single vial unit (SVU) technology for continuous and controlled freeze-drying technology, particularly to stabilize novel […]

250

Application of base editors in organoids opens new doors for cancer research

Researchers from the Organoid group (Hubrecht Institute, Utrecht University)) and the Princess Máxima Center (Utrecht, The Netherlands) have taken steps to advance cancer tumour models by using base editors to simultaneously introduce multiple cancer-related mutations into healthy organoids. They thereby succeeded in efficiently making tumour organoids that model liver, colorectal and endometrial cancer. The results […]